Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review

Research output: Contribution to journalJournal articleResearchpeer-review

  • B B Thompson
  • Y Béjot
  • V Caso
  • Jaime Castillo
  • M L Flaherty
  • C Foerch
  • K Ghandehari
  • M Giroud
  • S M Greenberg
  • H Hallevi
  • J C Hemphill
  • P Heuschmann
  • S Juvela
  • K Kimura
  • P K Myint
  • Y Nagakane
  • H Naritomi
  • S Passero
  • M R Rodríguez-Yáñez
  • J Roquer
  • J Rosand
  • N S Rost
  • P Saloheimo
  • V Salomaa
  • J Sivenius
  • T Sorimachi
  • M Togha
  • K Toyoda
  • W Turaj
  • K N Vemmos
  • C D A Wolfe
  • D Woo
  • E E Smith
Antiplatelet therapy (APT) promotes bleeding; therefore, APT might worsen outcome in patients with intracerebral hemorrhage (ICH). We performed a systematic review and meta-analysis to address the hypothesis that pre-ICH APT use is associated with mortality and poor functional outcome following ICH.
Original languageEnglish
JournalNeurology
Volume75
Issue number15
Pages (from-to)1333-42
Number of pages10
ISSN0028-3878
DOIs
Publication statusPublished - 12 Oct 2010

ID: 34146972